Related Experiment Video
Updated: Nov 10, 2025
05:25
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
Published on: July 14, 2023
1.7K
Quantitative multiplexed strategies for human Lyme disease serological testing.
Eunice Chou1,2, Armond Minor1, Nathaniel C Cady1
1Nanobioscience Constellation, College of Nanoscale Science & Engineering, State University of New York Polytechnic Institute, Albany, NY 12203, USA.
Experimental Biology and Medicine (Maywood, N.J.)
|April 2, 2021
Summary
Multiplexed diagnostic tests offer a promising solution for accurate Lyme disease diagnosis by detecting immune responses to multiple bacterial antigens. These advanced methods may also help monitor treatment effectiveness.
Area of Science:
- Infectious Diseases
- Immunology
- Diagnostic Medicine
Background:
- Lyme disease diagnosis relies on serological testing, but current methods vary in accuracy and lack a reliable indicator for treatment resolution.
- The diverse immune responses to various Borrelia antigens complicate accurate Lyme disease diagnostics.
Purpose of the Study:
- To review and compare state-of-the-art multiplexed diagnostic approaches for Lyme disease.
- To assess the diagnostic accuracy and potential for treatment monitoring of these advanced methods.
Main Methods:
- Review of current multiplexed diagnostic technologies for Lyme disease.
- Comparative analysis of diagnostic accuracy and treatment monitoring capabilities.
Main Results:
- Multiplexed assays show potential for improved sensitivity and specificity in Lyme disease detection.
- These approaches may offer a way to track disease resolution post-treatment, addressing a current diagnostic gap.
Conclusions:
- Multiplexed testing strategies are crucial for prompt and accurate Lyme disease diagnosis.
- Further development and validation of multiplexed diagnostics are needed for clinical application and treatment monitoring.
